Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC2376 Gsk2838232
Novel human immune virus (HIV) maturation inhibitor
More description
DCC2375 Gsk-2807
Novel potent and selective, SAM-competitive inhibitor of SMYD3
More description
DCC2374 Gsk270822a
Novel selective inhibitor of G protein-coupled receptor kinase 2 (GRK2)
More description
DCC2373 Gsk2565363c
Betulin derivative as antitumor agent
More description
DCC2372 Gsk246053
Specific ATPase competitive kinesin-5 inhibitor
More description
DCC2371 Gsk-239512
Novel selective histamine H3 receptor antagonist
More description
DCC2370 Gsk237701a
Novel I-kappa-B kinase-3 (IKK3) inhibitor
More description
DCC2369 Gsk2263167
Novel S1P1 receptor agonist
More description
DCC2368 Gsk2256294a
Novel highly potent, reversible soluble epoxide hydrolase (sEH) inhibitor, exhibiting potent cell-based activity, a concentration-dependent inhibition of the conversion of 14,15-EET to 14,15-DHET, attenuating cigarette smoke-induced inflammation by both i
More description
DCC2367 Gsk223
Selective inhibitor of iE-DAP-stimulated IL-8 release via the NOD1 signaling pathway
More description
DCC2366 Gsk2220400a
Inhibitor of insulin receptor, also tageting IGF-1R and ALK
More description
DCC2365 Gsk2188764
Novel inhibitor of T. brucei IPMK, partially inhibiting rTbIPMK activity
More description
DCC2364 Gsk2163632a
Novel insulin-like growth factor 1 receptor inhibitor, binding to a novel region of the GRK active site cleft that could likely be exploited to achieve more selectivity
More description
DCC2363 Gsk2141795 Hydrochloride
Novel AKT Inhibitor, Enhancing Anti-Tumor Effects in Combination with the MEK Inhibitor
More description
DCC2362 Gsk207040
Novel selective non-imidazole histamine H 3 receptor antagonist
More description
DCC2361 Gsk2008607
Novel competitive inhibitor of rTbIPMK with respect to Ins(1,4,5)P3
More description
DCC2360 Gsk1997132b
Novel potent, metabolically stable and centrally penetrant PPARγ partial agonist
More description
DCC2359 Gsk1910364
Novel inhibitor of EPHX2 (epoxide hydrolase 2, alias soluble epoxide hydrolase or sEH), up-regulating cytoprotective genes and down-regulating proinflammatory cytokine production
More description
DCC2358 Gsk189254
Potent and selective H3 histamine receptor inverse agonist
More description
DCC2357 Gsk1829820a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC2355 Gsk1723980
Novel noncompetitive inhibitor of rTbIPMK
More description
DCC2354 Gsk1452498a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC2353 Gsk1452496a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC2352 Gsk1379767a
Novel dual inhibitor of BPTF and Brd4
More description
DCC2351 Gsk1370319a
Novel specific P2X(7) receptor antagonist
More description
DCC2350 (BrMT)2
Non-peptidic snail toxin; Activator of the Kv1.1 potassium ion channel
More description
DCC2349 Gsk-1264
Novel allosteric inhibitor of human immunodeficiency virus (HIV) integrase, blocking viral replication and abnormal multimerization involving specific protein domains
More description
DCC2348 Gsk1180781a
Novel selective inhibitor of MmpL3 mutation
More description
DCC2347 Gsk1104252a
Potent and selective GPR119 agonist
More description
DCC2346 Gsk1030058a
Novel inhibitor of polo-like kinase
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X